SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-038616
Filing Date
2021-06-07
Accepted
2021-06-07 16:34:33
Documents
1
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6817
  Complete submission text file 0001209191-21-038616.txt   8171
Mailing Address C/O AXOVANT SCIENCES, INC. 320 WEST 37TH STREET, 5TH FLOOR NEW YORK NY 10018
Business Address
FALBERG KATHRYN E (Reporting) CIK: 0001206977 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38419 | Film No.: 21999944

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Issuer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations